Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 154

1.

Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.

Agabio R, Sinclair JM, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Heydtman M, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, de Beaurepaire R, Leggio L.

Lancet Psychiatry. 2018 Nov 6. pii: S2215-0366(18)30303-1. doi: 10.1016/S2215-0366(18)30303-1. [Epub ahead of print] No abstract available.

PMID:
30413394
2.

Preliminary results of a controlled educational intervention on alcohol related harm among medical students with a 12-month follow-up.

Jaworowski S, Raveh-Brawer D, Gropp C, Haber PS, Golmard JL, Mergui J.

Isr J Psychiatry Relat Sci. 2018;55(2):37-39.

3.

Alcohol Related Harm: Knowledge Assessment of Medical and Nursing Staff in a General Hospital.

Jaworowski S, Raveh-Brawer D, Gropp C, Haber PS, Golmard JL, Mergui J.

Isr J Psychiatry Relat Sci. 2018;55(2):32-36.

4.

Neurometabolite Levels in Alcohol Use Disorder Patients During Baclofen Treatment and Prediction of Relapse to Heavy Drinking.

Morley KC, Lagopoulos J, Logge W, Chitty K, Baillie A, Haber PS.

Front Psychiatry. 2018 Sep 4;9:412. doi: 10.3389/fpsyt.2018.00412. eCollection 2018.

5.

Impact of acutely behavioural disturbed patients in the emergency department: A prospective observational study.

Oliver M, Adonopulos AA, Haber PS, Dinh MM, Green T, Wand T, Vitte A, Chalkley D.

Emerg Med Australas. 2018 Sep 19. doi: 10.1111/1742-6723.13173. [Epub ahead of print]

PMID:
30230230
6.

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).

Mersiades AJ, Tognela A, Haber PS, Stockler M, Lintzeris N, Simes J, McGregor I, Olver I, Allsop DJ, Gedye C, Kirby AC, Morton RL, Fox P, Clarke S, Briscoe K, Aghmesheh M, Wong N, Walsh A, Hahn C, Grimison P.

BMJ Open. 2018 Sep 12;8(9):e020745. doi: 10.1136/bmjopen-2017-020745.

7.

Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).

Morley KC, Kranzler HR, Luquin N, Baillie A, Shanahan M, Trent R, Teesson M, Haber PS.

Trials. 2018 Aug 16;19(1):443. doi: 10.1186/s13063-018-2824-z.

8.

N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research.

Morley KC, Baillie A, Van Den Brink W, Chitty KE, Brady K, Back SE, Seth D, Sutherland G, Leggio L, Haber PS.

Expert Opin Investig Drugs. 2018 Aug;27(8):667-675. doi: 10.1080/13543784.2018.1501471. Epub 2018 Aug 1. Review.

PMID:
30019966
9.

Moderation of baclofen response by a GABAB receptor polymorphism: results from the BacALD randomized controlled trial.

Morley KC, Luquin N, Baillie A, Fraser I, Trent RJ, Dore G, Phung N, Haber PS.

Addiction. 2018 Dec;113(12):2205-2213. doi: 10.1111/add.14373. Epub 2018 Jul 24.

PMID:
29968397
10.

Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial.

Morley KC, Baillie A, Fraser I, Furneaux-Bate A, Dore G, Roberts M, Abdalla A, Phung N, Haber PS.

Br J Psychiatry. 2018 Jun;212(6):362-369. doi: 10.1192/bjp.2018.13. Epub 2018 May 2.

PMID:
29716670
11.

Translating Evidence-Based Practice for Managing Comorbid Substance Use and Mental Illness Using a Multimodal Training Package.

Louie E, Giannopoulos V, Baillie A, Uribe G, Byrne S, Deady M, Teesson M, Baker A, Haber PS, Morley KC.

J Dual Diagn. 2018 Feb 28:1-9. doi: 10.1080/15504263.2018.1437496. [Epub ahead of print]

PMID:
29488830
12.

Characteristics of Suicide Attempters and Ideators in a Clinical Sample of Substance Users.

Morley KC, Sitharthan G, Haber PS, Tucker P, Sitharthan T.

Subst Use Misuse. 2018 Sep 19;53(11):1811-1818. doi: 10.1080/10826084.2018.1435075. Epub 2018 Feb 8.

PMID:
29419353
13.

Evaluation of a novel method for the analysis of alcohol biomarkers: Ethyl glucuronide, ethyl sulfate and phosphatidylethanol.

Nguyen VL, Paull P, Haber PS, Chitty K, Seth D.

Alcohol. 2018 Mar;67:7-13. doi: 10.1016/j.alcohol.2017.08.009. Epub 2017 Aug 31.

PMID:
29304397
14.

Vertical transmission of hepatitis C: Testing and health-care engagement.

Reid S, Day CA, Bowen DG, Minnis J, Ludlow J, Jacobs S, Gordon A, Haber PS.

J Paediatr Child Health. 2018 Jun;54(6):647-652. doi: 10.1111/jpc.13832. Epub 2018 Jan 2.

PMID:
29292561
15.

Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis.

Whitfield JB, Masson S, Liangpunsakul S, Hyman J, Mueller S, Aithal G, Eyer F, Gleeson D, Thompson A, Stickel F, Soyka M, Daly AK, Cordell HJ, Liang T, Foroud T, Lumeng L, Pirmohamed M, Nalpas B, Bence C, Jacquet JM, Louvet A, Moirand R, Nahon P, Naveau S, Perney P, Podevin P, Haber PS, Seitz HK, Day CP, Mathurin P, Morgan TM, Seth D; GenomALC Consortium.

Alcohol. 2018 Feb;66:1-7. doi: 10.1016/j.alcohol.2017.07.006. Epub 2017 Sep 23.

PMID:
29277282
16.

A Mobile Text Message Intervention to Reduce Repeat Suicidal Episodes: Design and Development of Reconnecting After a Suicide Attempt (RAFT).

Larsen ME, Shand F, Morley K, Batterham PJ, Petrie K, Reda B, Berrouiguet S, Haber PS, Carter G, Christensen H.

JMIR Ment Health. 2017 Dec 13;4(4):e56. doi: 10.2196/mental.7500.

17.

Applications and Challenges for the Use of Phosphatidylethanol Testing in Liver Disease Patients (Mini Review).

Nguyen VL, Haber PS, Seth D.

Alcohol Clin Exp Res. 2018 Feb;42(2):238-243. doi: 10.1111/acer.13558. Epub 2017 Dec 28. Review.

PMID:
29155439
18.

Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment.

Haber PS, Elsayed M, Espinoza D, Lintzeris N, Veillard AS, Hallinan R.

Drug Alcohol Depend. 2017 Dec 1;181:132-139. doi: 10.1016/j.drugalcdep.2017.09.024. Epub 2017 Oct 13.

PMID:
29054032
19.

Harnessing advances in computer simulation to inform policy and planning to reduce alcohol-related harms.

Atkinson JA, Knowles D, Wiggers J, Livingston M, Room R, Prodan A, McDonnell G, O'Donnell E, Jones S, Haber PS, Muscatello D, Ezard N, Phung N, Freebairn L, Indig D, Rychetnik L, Ananthapavan J, Wutzke S; alcohol modelling consortium.

Int J Public Health. 2018 May;63(4):537-546. doi: 10.1007/s00038-017-1041-y. Epub 2017 Oct 19.

20.

Pharmacotherapeutic agents in the treatment of methamphetamine dependence.

Morley KC, Cornish JL, Faingold A, Wood K, Haber PS.

Expert Opin Investig Drugs. 2017 May;26(5):563-578. doi: 10.1080/13543784.2017.1313229. Epub 2017 Apr 7. Review.

PMID:
28351169

Supplemental Content

Loading ...
Support Center